Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry - Takeaways - MDSpire

Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry

  • By

  • Mustafa Yildirim

  • Christian Salbach

  • Johannes Dürr

  • Matthias Mueller-Hennessen

  • Hugo A. Katus

  • Norbert Frey

  • Evangelos Giannitsis

  • April 15, 2026

  • 0 min

Share

  • 1

    The study assesses type 1 and type 2 NSTEMI prevalence in atrial fibrillation patients using coronary angiography for accurate diagnosis.

  • 2

    Type 1 MI results from coronary plaque issues, while type 2 MI stems from oxygen demand-supply mismatch, often without significant stenosis.

  • 3

    The HERA-FIB registry includes a high rate of coronary angiography, allowing for better evaluation of myocardial infarction subtypes.

  • 4

    Atrial fibrillation patients frequently diagnosed with type 2 MI may have undiagnosed type 1 MI due to lack of systematic angiographic evaluation.

  • 5

    The study's findings aim to improve understanding of clinical outcomes and characteristics associated with NSTEMI in AF patients.

Original Source(s)

Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry

  • by Mustafa Yildirim, Christian Salbach, Johannes Dürr, Matthias Mueller-Hennessen, Hugo A. Katus, Norbert Frey, Evangelos Giannitsis

  • April 15, 2026

Related Content

Do Urate Targets Influence CV Risk?

Researchers examine whether achieving treat-to-target serum urate levels with urate-lowering treatment affects long-term cardiovascular outcomes in patients with gout.

Flu Vaccination Linked to Lower Heart, Stroke Risk After Infection

A Danish registry study suggests prior influenza vaccination is associated with lower short-term cardiovascular risk following breakthrough infection.

Antivirals Linked to Lower Hospitalization in Influenza

Matched cohort study in nonhospitalized patients